throbber

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`STANDARD FOR FISH OILS
`
`CODEX STAN 329-2017
`
`Adopted in 2017.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`RIMFROST EXHIBIT 1147 Page 0001
`
`

`

`CODEX STAN 329-2017
`
`1.
`
`SCOPE
`
`2
`
`
`
`This Standard applies to the fish oils described in section 2 that are presented in a state for human consumption.
`For the purpose of this Standard, the term fish oils refers to oils derived from fish and shellfish as defined in
`section 2 of the Code of Practice for Fish and Fishery Products (CAC/RCP 52-2003)1. This standard only
`applies to fish oils used in food and in food supplements where those are regulated as foods.
`
`2.
`
`DESCRIPTION
`
`
`
`
`
`
`
`Fish oils means oils intended for human consumption derived from the raw material as defined in Section 2 of
`the Code of Practice for Fish and Fishery Products (CAC/RCP 52-2003). Processes to obtain fish oil for human
`consumption may involve, but are not limited to, extraction of crude oil from raw material and refining of that
`crude oil. Fish oils and concentrated fish oils are primarily composed of glycerides of fatty acids whereas
`concentrated fish oils ethyl esters are primarily composed of fatty acids ethyl esters. Fish oils may contain
`other lipids and unsaponifiable constituents naturally present.
`
`Crude fish oils and crude fish liver oils are oils intended for human consumption after they have undergone
`further processing, e.g. refining and purification and have to comply with section 3.1, as applicable, as well as
`with sections 4, 6.1 and 7. Fish oils intended for direct human consumption shall comply with all sections of
`this standard.
`
`The refined fish oil production process typically includes several steps such as repeated heating at high
`temperatures as well as alkali/ acid treatments and repeated removal of the water phase. Fish oils may also
`be subjected to processing steps (e.g. solvent extraction, saponification, re-esterification, trans-esterification).
`
`2.1 Named fish oils are derived from specific raw materials which are characteristic of the major fish or shellfish
`taxon from which the oil is extracted.
`
`2.1.1 Anchovy oil is derived from Engraulis ringens and other species of the genus Engraulis (Engraulidae).
`
`2.1.2 Tuna oil is derived from the species of the genus Thunnus and from the species Katsuwonus pelamis
`(Scombridae).
`
`2.1.3 Krill oil is derived from Euphausia superba. The major components are triglycerides and phospholipids.
`
`2.1.4 Menhaden oil is derived from the genera Brevootia and Ethmidium (Clupeidae).
`
`2.1.5 Salmon oil is derived from the family Salmonidae.
`
`2.2 Fish oils (unnamed) are derived from one or more species of fish or shellfish. This includes also mixtures
`with fish liver oils.
`
`2.3 Named fish liver oils are derived from the livers of fish and are composed of fatty acids, vitamins or other
`components that are representative of the livers from the species from which the oil is extracted.
`
`2.3.1 Cod liver oil is derived from the liver of wild cod, Gadus morhua L and other species of Gadidae.
`
`2.4 Fish liver oil (unnamed) are derived from the livers of one or more species of fish.
`
`2.5 Concentrated fish oils are derived from fish oils described in Sections 2.1 to 2.4 which have been subjected
`to processes that may involve, but are not limited to, hydrolysis, fractionation, winterization and/or re-
`esterification to increase the concentration of specific fatty acids.
`
`2.5.1 Concentrated fish oil contains 35 to 50 w/w % fatty acids as sum of C20:5 (n-3) eicosapentaenoic acid (EPA)
`and C22:6 (n-3) docosahexaenoic acid (DHA).
`
`2.5.2 Highly concentrated fish oil contains more than 50 w/w % fatty acids as sum of EPA and DHA.
`
`2.6 Concentrated fish oils ethyl esters are derived from fish oils described in Section 2.1 to 2.4 and are primarily
`composed of fatty acids ethyl esters.
`
`2.6.1 Concentrated fish oil ethyl esters contain fatty acids as esters of ethanol of which 40 to 60 w/w % are as
`sum of EPA and DHA.
`
`2.6.2 Highly concentrated fish oil ethyl esters contain fatty acids as esters of ethanol of which more than 60
`w/w % are as sum of EPA and DHA.
`
`
`1 Fish: Any of the cold-blooded (ecothermic) aquatic vertebrates. Amphibians and aquatic reptiles are not included. Shellfish:
`Those species of aquatic molluscs and crustaceans that are commonly used for food.
`
`
`
`RIMFROST EXHIBIT 1147 Page 0002
`
`

`

`CODEX STAN 329-2017
`
`3
`
`3.
`
`ESSENTIAL COMPOSITION AND QUALITY FACTORS
`
`3.1 GLC ranges of fatty acid composition (expressed as percentages of total fatty acids)
`
`Sample of fish oils described in sections 2.1 and 2.3 shall fall within the appropriate ranges specified in Table
`1. Supplementary criteria, for example national geographical and/or climatic variations may be considered, as
`necessary, to confirm that a sample is in compliance with the Standard.
`
`3.2 Other essential compositional criteria
`
`For oil from Engraulis ringens (2.1.1) the sum of EPA and DHA has to be at least 27 % (expressed as
`percentage of total fatty acids).
`
`For krill oils (2.1.3) the content of phospholipids shall be at least 30 w/w %.
`
`Concentrated fish oils (2.5.1) and highly concentrated fish oils (2.5.2) shall contain at least 50 w/w % of fatty
`acids as sum of EPA and DHA in the form of triglycerides and/or phospholipids.
`
`3.3 Quality parameters
`
`Note: this section does not apply to flavoured fish oils where the added flavourings may interfere with the
`analytical determination of oxidation parameters.
`
`3.3.1 Fish oils, fish liver oils, concentrated fish oils, and concentrated fish oils ethyl esters (Section 2.1. to
`2.6) with the exception of oils dealt with in Section 3.3.2 shall comply with the following:
`
`Acid value
`
`
`
`≤ 3 mg KOH/g
`
`Peroxide value
`
`≤ 5 milliequivalent of active oxygen/kg oil
`
`Anisidine value
`
`≤ 20
`
`Total oxidation value (ToTox)2
`
`≤ 26
`
`3.3.2 Fish oils with a high phospholipid concentration of 30% or more such as krill oil (Section 2.1.3) shall
`comply with the following:
`
`Acid value
`
`≤ 45 mg KOH/g
`
`Peroxide value
`
`≤ 5 milliequivalent of active oxygen/kg oil
`
`3.4 Vitamins
`
`Fish liver oils except of deep sea shark liver oil (Sections 2.3 and 2.4) shall comply with following:
`
`Vitamin A
`
`≥ 40 µg of retinol equivalents/ml of oil
`
`Vitamin D
`
`≥ 1.0 µg/ml
`
`Losses during processing may be restored (see Section 2.4. of CAC/GL 9-1987) by the addition of:
`
`Vitamin A and its esters
`
`Vitamin D
`
`Maximum levels for vitamins A and D should be in accordance with the needs of each individual country
`including, where appropriate, the prohibition of the use of particular vitamins.
`
`4.
`
`FOOD ADDITIVES
`
`
`
`Antioxidants, sequestrants, antifoaming agents, and emulsifiers used in accordance with Tables 1 and 2 of the
`General Standard for Food Additives (CODEX STAN 192-1995), in food category 02.1.3 Lard, tallow, fish oil,
`and other animal fats are acceptable for use in foods conforming to this standard.
`
`
`2 Total oxidation value (ToTox) = 2 x Peroxide value + 1 x Anisidine value
`
`Explanatory note: Oxidation of fish oils is a sequential process: following an initial raise of peroxide value, the anisidine value
`rises. The peroxide value is therefore a parameter for primary oxidation products, the anisidine value for secondary oxidation
`products. The parameter ToTox, which means "total oxidation of oil", was established to avoid that both of these oxidation
`products are present at maximum levels. The maximum allowed ToTox value is set separately and lower than the sum of the
`individual possible maximum limits set for peroxide and anisidine values.
`
`
`
`RIMFROST EXHIBIT 1147 Page 0003
`
`

`

`CODEX STAN 329-2017
`
`The following additives may be used in addition:
`
`INS
`
`Additive name
`
`Maximum level
`
`4
`
`Antioxidant
`
`300
`
`Ascorbic acid, L-
`
`304, 305
`
`Ascorbyl esters
`
`307a, b, c
`
`Tocopherols
`
`GMP
`
`2500 mg/kg, as ascorbyl stearate
`
`6000 mg/kg, singly or in combination
`
`Emulsifier
`
`322 (i)
`
`471
`
`Lecithin
`
`Mono- and di-glycerides of fatty acids
`
`GMP
`
`GMP
`
`The flavourings used in products covered by this standard should comply with the Guidelines for the Use of
`Flavourings (CAC/GL 66-2008).
`
`5.
`
`CONTAMINANTS
`
`The products covered by this Standard shall comply with the Maximum Levels of the General Standard for
`Contaminants and Toxins in Food and Feed (CODEX STAN 193-1995).
`
`The products covered by this Standard shall comply with the maximum residue limits for pesticides and/or
`veterinary drugs established by the Codex Alimentarius Commission.
`
`6.
`
`HYGIENE
`
`6.1 General hygiene
`
`It is recommended that the products covered by the provisions of this Standard be prepared and handled in
`accordance with the appropriate sections of the General Principles of Food Hygiene (CAC/RCP 1-1969), the
`Code of Practice for Fish and Fishery Products (CAC/RCP 52-2003), and Code of Hygienic Practice for the
`Storage and Transport of Edible Fats and Oils in Bulk (CAC/RCP 36-1987).
`
`6.2 Microbiological criteria
`
`The products should comply with any microbiological criteria established in accordance with the Principles and
`Guidelines for the Establishment and Application of Microbiological Criteria Related to Foods (CAC/GL 21-
`1997).
`
`7.
`
`LABELLING
`
`The requirements of the General Standard for the Labelling of Prepackaged Foods (CODEX STAN 1-1985)
`and of the Guidelines on Nutrition Labelling (CAC/GL 2-1985) apply to this standard.
`
`7.1 Name of the food
`
`The name of the fish oil shall conform to the descriptions given in Section 2 of this Standard. For salmon oil
`the label shall specify the source of the raw material (wild or farmed).
`
`7.2 Labelling on non-retail containers
`
`Information on the above labelling requirements shall be given either on the container or in accompanying
`documents, except that the name of the food, lot identification and the name and address of the manufacturer
`or packer shall appear on the container.
`
`However, lot identification and the name and address of the manufacturer or packer may be replaced by an
`identification mark, provided that such a mark is clearly identifiable with the accompanying documents.
`
`For crude fish oils and crude fish liver oils the label shall indicate that these oils are intended for human
`consumption only after they have undergone further processing.
`
`7.3 Other labelling requirements
`
`For fish liver oils (Sections 2.3 and 2.4) the content in vitamin A and vitamin D, naturally present or restored,
`shall be given if required by country of retail sale.
`
`For all fish oils covered by this standard the content of EPA and DHA shall be given if required by country of
`retail sale.
`
`
`
`RIMFROST EXHIBIT 1147 Page 0004
`
`

`

`CODEX STAN 329-2017
`
`5
`
`8.
`
`METHODS OF ANALYSIS AND SAMPLING
`
`For checking the compliance with this standard, the methods of analysis and sampling contained in the
`Recommended Methods of Analysis and Sampling (CODEX STAN 234-1999) relevant to the provisions in this
`standard, shall be used
`
`
`
`
`
`
`
`
`RIMFROST EXHIBIT 1147 Page 0005
`
`

`

`CODEX STAN 329-2017
`
`6
`
`Table 1: Fatty acid (FA) composition of named fish oil and fish liver oil categories as determined by
`gas liquid chromatography from authentic samples (expressed as percentage of total fatty acids) (see
`Section 3.1 of the Standard)
`
`Fatty acids
`
`Anchovy
`(Section
`2.1.1)
`
`Tuna
`(Section
`2.1.2)
`
`Krill
`(Section
`2.1.3)
`
`Menhaden
`(Section
`2.1.4)
`
`Salmon
`(Section 2.1.5)
`
`Wild
`
`Farmed
`
`Cod
`Liver
`(Section
`2.3.1)
`
`C14:0 myristic acid
`
`2.7-11.5
`
`ND-5.0
`
`5.0-13.0
`
`8.0-11.0
`
`2.0-5.0
`
`1.5-5.5
`
`2.0-6.0
`
`C15:0 pentadecanoic
`acid
`
`ND-1.5
`
`ND-2.0
`
`NA
`
`ND-1.0
`
`ND-1.0
`
`ND-0.5
`
`ND-0.5
`
`C16:0 palmitic acid
`
`13.0-22.0 14.0-24.0 17.0-24.6 18.0-20.0
`
`10.0-16.0
`
`6.5-12.0
`
`7.0-14.0
`
`4.0-12.6
`
`ND-12.5
`
`2.5-9.0
`
`9.0-13.0
`
`4.0-6.0
`
`2.0-5.0
`
`4.5-11.5
`
`ND-2.0
`
`ND-3.0
`
`NA
`
`NA
`
`ND-1.0
`
`ND-1.0
`
`ND-0.5
`
`NA
`
`2.5-4.0
`
`2.0-5.0
`
`2.0-5.0
`
`1.0-4.0
`
`C16:1 (n-7) palmitoleic
`acid
`
`C17:0 heptadecanoic
`acid
`
`C18:0 stearic acid
`
`1.0-7.0
`
`ND-7.5
`
`C18:1 (n-7) vaccenic
`acid
`
`1.7-3.7
`
`ND– 7.0
`
`4.7-8.1
`
`2.5-3.5
`
`1.5-2.5
`
`NA
`
`2.0–7.0
`
`C18:1 (n-9) oleic acid
`
`3.6-17.0
`
`10.0-25.0
`
`6.0-14.5
`
`5.5-8.5
`
`8.0-16.0
`
`30.0-47.0 12.0-21.0
`
`C18:2 (n-6) linoleic acid
`
`ND-3.5
`
`ND-3.0
`
`ND-3.0
`
`2.0-3.5
`
`1.5-2.5
`
`8.0-15.0
`
`0.5-3.0
`
`C18:3 (n-3) linolenic
`acid
`
`C18:3 (n-6) γ-linolenic
`acid
`
`ND-7.0
`
`ND-2.0
`
`0.1-4.7
`
`ND-2.0
`
`ND-2.0
`
`3.0-6.0
`
`ND-2.0
`
`ND-5.0
`
`ND-4.0
`
`NA
`
`ND-2.5
`
`ND-2.0
`
`ND-0.5
`
`NA
`
`0.5-4.5
`
`C18:4 (n-3) stearidonic
`acid
`
`ND-5.0
`
`ND-2.0
`
`1.0-8.1
`
`1.5-3.0
`
`1.0-4.0
`
`0.5-1.5
`
`C20:0 arachidic acid
`
`ND-1.8
`
`ND-2.5
`
`C20:1 (n-9) eicosenoic
`acid
`
`C20:1 (n-11) eicosenoic
`acid
`
`C20:4 (n-6) arachidonic
`acid
`
`C20:4 (n-3)
`eicosatetraenoic acid
`
`C20:5 (n-3)
`eicosapentaenoic acid
`
`C21:5 (n-3)
`heneicosapentaenoic
`acid
`
`ND-4.0
`
`ND-2.5
`
`NA
`
`NA
`
`0.1-0.5
`
`ND-0.5
`
`0.1-0.5
`
`NA
`
`ND-0.5
`
`2.0-10.0
`
`1.5-7.0
`
`5.0-17.0
`
`ND-4.0
`
`ND-3.0
`
`NA
`
`0.5-2.0
`
`NA
`
`NA
`
`1.0-5.5
`
`ND-2.5
`
`ND-3.0
`
`NA
`
`ND-2.0
`
`0.5-2.5
`
`ND-1.2
`
`ND-1.5
`
`ND-2.0
`
`ND-1.0
`
`NA
`
`NA
`
`1.0-3.0
`
`0.5-1.0
`
`ND-2.0
`
`5.0-26.0
`
`2.5-9.0
`
`14.3-28.0 12.5-19.0
`
`6.5-11.5
`
`2.0-6.0
`
`7.0-16.0
`
`ND-4.0
`
`ND-1.0
`
`NA
`
`0.5-1.0
`
`ND-4.0
`
`NA
`
`ND-1.5
`
`C22:1 (n-9) erucic acid
`
`ND-2.3
`
`ND-2.0
`
`ND-1.5
`
`0.1-0.5
`
`ND-1.5
`
`3.0-7.0
`
`ND-1.5
`
`C22:1 (n-11) cetoleic
`acid
`
`C22:5 (n-3)
`docosapentaenoic acid
`
`C22:6 (n-3)
`docosahexaenoic acid
`
`ND-5.6
`
`ND-1.0
`
`NA
`
`ND-0.1
`
`1.0-1.5
`
`NA
`
`5.0-12.0
`
`ND-4.0
`
`ND-3.0
`
`ND-0.7
`
`2.0-3.0
`
`1.5-3.0
`
`1.0-2.5
`
`0.5-3.0
`
`4.0-26.5
`
`21.0-42.5
`
`7.1-15.7
`
`5.0-11.5
`
`6.0-14.0
`
`3.0-10.0
`
`6.0-18.0
`
`ND = non-detect, defined as ≤0.05%
`NA = not applicable or available
`
`
`
`
`RIMFROST EXHIBIT 1147 Page 0006
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket